On the 24th, DeepNoid announced that it has signed a supply contract with Pohang Se-myung Christian Hospital for three medical AI solutions, including 'M4CXR,' a generative AI-based solution for drafting preliminary reports on chest X-rays.
This marks the first time M4CXR is being supplied to a private general hospital through direct hospital procurement rather than as part of a government-supported project. The solution analyzes chest X-ray images to generate preliminary reports and supports initial interpretation by medical staff.
Pohang Se-myung Christian Hospital, which operates 745 beds, is a regional hub general hospital in the eastern coastal area of Gyeongsangbuk-do. The hospital plans to use medical AI solutions to improve the speed of image interpretation and response capabilities for emergency and critically ill patients.
The contract includes 'DeepNeuro,' a brain aneurysm imaging interpretation and diagnostic support solution, and 'DeepChest,' a multi-pulmonary disease detection solution based on chest X-rays, alongside M4CXR. DeepNoid will integrate its medical AI product line for brain and chest image interpretation into the hospital.
A representative of Pohang Se-myung Christian Hospital stated, "This introduction is one pillar of the hospital's initiative to transform into a smart general hospital," adding, "We expect it to contribute to enhancing capabilities in responding to emergency and critically ill patients."
Choi Woo-sik, CEO of DeepNoid, said, "Regional general hospitals provide a wide range of medical services from emergency care to health checkups, making them ideal for verifying the practical effectiveness of AI," and added, "Based on field experience, we will grow into a medical AI agent company that supports not only interpretation but the entire treatment process."
Last month, DeepNoid announced its plan to transform into a medical AI service company encompassing medical AI solutions, infrastructure, and agents. This month, it completed the regulatory approval process with the Ministry of Food and Drug Safety for 'ExonFlow,' an remote reading operation platform.
in TECH
